Proteomics and pathological analysis of human brain samples

Proteomics and pathological analysis of human brain samples - Proteomics and pathological analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048498

Enrollment

Registered

2022-07-31

Start date

2022-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pathological diagnosis

Exclusion criteria

Exclusion criteria: Fulfill pathological diagnoses other than those of the diseases covered in the current study.

Design outcomes

Primary

Measure	Time frame
Identification of variable protein groups in human brain diseases by proteome analysis, and their expression profiles. Quantitative and spatial expression distribution of variable protein groups by histopathology. The amount and distribution of binding sites of radiolabeled drugs as candidate molecular markers by autoradiography.	—

Countries

Japan

Contacts

Public ContactYuhei Takado

National Institutes for Quantum Science and Technology Institute for Quantum Medical Science

takado.yuhei@qst.go.jp0432063251

Outcome results